Globus Medical Inc (GMED)
50.57
+0.20
(+0.40%)
USD |
NYSE |
Apr 26, 16:00
50.57
0.00 (0.00%)
After-Hours: 17:25
Globus Medical Enterprise Value: 6.718B for April 25, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 25, 2024 | 6.718B |
April 24, 2024 | 6.863B |
April 23, 2024 | 6.840B |
April 22, 2024 | 6.837B |
April 19, 2024 | 6.716B |
April 18, 2024 | 6.770B |
April 17, 2024 | 6.831B |
April 16, 2024 | 6.911B |
April 15, 2024 | 6.915B |
April 12, 2024 | 6.894B |
April 11, 2024 | 7.003B |
April 10, 2024 | 7.089B |
April 09, 2024 | 7.166B |
April 08, 2024 | 7.097B |
April 05, 2024 | 6.916B |
April 04, 2024 | 6.833B |
April 03, 2024 | 6.985B |
April 02, 2024 | 6.915B |
April 01, 2024 | 7.092B |
March 28, 2024 | 7.161B |
March 27, 2024 | 7.082B |
March 26, 2024 | 6.888B |
March 25, 2024 | 6.824B |
March 22, 2024 | 6.942B |
March 21, 2024 | 6.957B |
Date | Value |
---|---|
March 20, 2024 | 6.916B |
March 19, 2024 | 6.936B |
March 18, 2024 | 6.892B |
March 15, 2024 | 6.858B |
March 14, 2024 | 6.921B |
March 13, 2024 | 7.392B |
March 12, 2024 | 7.384B |
March 11, 2024 | 7.359B |
March 08, 2024 | 7.394B |
March 07, 2024 | 7.261B |
March 06, 2024 | 7.276B |
March 05, 2024 | 7.166B |
March 04, 2024 | 7.372B |
March 01, 2024 | 7.271B |
February 29, 2024 | 7.208B |
February 28, 2024 | 7.272B |
February 27, 2024 | 7.539B |
February 26, 2024 | 7.468B |
February 23, 2024 | 7.520B |
February 22, 2024 | 7.380B |
February 21, 2024 | 7.345B |
February 20, 2024 | 7.231B |
February 16, 2024 | 7.185B |
February 15, 2024 | 7.200B |
February 14, 2024 | 7.091B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
3.189B
Minimum
Mar 16 2020
8.020B
Maximum
Sep 08 2021
5.799B
Average
5.695B
Median
Jan 27 2021
Enterprise Value Benchmarks
Stryker Corp | 138.15B |
Intuitive Surgical Inc | 127.63B |
Glaukos Corp | 5.012B |
PROCEPT BioRobotics Corp | 2.459B |
Paragon 28 Inc | 777.85M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 15.03M |
Revenue (Quarterly) | 616.53M |
Total Expenses (Quarterly) | 590.58M |
EPS Diluted (Quarterly) | 0.11 |
Gross Profit Margin (Quarterly) | 56.94% |
Profit Margin (Quarterly) | 2.44% |
Earnings Yield | 2.31% |
Operating Earnings Yield | 3.49% |
Normalized Earnings Yield | 3.079 |